BIOCON - Biocon Limited

Biocon Limited Share Market Related News
-: Stock News :- BIOCON 07-06-2022 To 07-06-2022
-: Stock News :- BIOCON 07-06-2022 To 07-06-2022

✔️ Biocon chief Kiran Majumdar-Shaw slams poor condition of Bengaluru roads

View Full Story
-: Stock News :- BIOCON 19-05-2022 To 19-05-2022
-: Stock News :- BIOCON 19-05-2022 To 19-05-2022

✔️ CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics
✔️ Biocon Biologics, Viatris, launch Abevmy in Canada
✔️ Biocon Biologics and Viatris launch their third oncology biosimilar in Canada

View Full Story
-: Stock News :- BIOCON 19-05-2022 To 18-05-2022
-: Stock News :- BIOCON 19-05-2022 To 18-05-2022

✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal

View Full Story
-: Stock News :- BIOCON 03-05-2022 To 18-05-2022
-: Stock News :- BIOCON 03-05-2022 To 18-05-2022

✔️ Ireland regulator reports manufacturing deficiency at Biocon's plant
✔️ Ireland regulator reports manufacturing deficiency at Biocon's Bengaluru plant
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal

View Full Story
-: Stock News :- BIOCON 30-04-2022 To 30-04-2022
-: Stock News :- BIOCON 30-04-2022 To 30-04-2022

✔️ Buy Biocon: target of Rs 420: Sharekhan
✔️ Neutral Biocon; target of Rs 410: Motilal Oswal
✔️ Hold Biocon; target of Rs 380: ICICI Direct

View Full Story
-: Stock News :- BIOCON 29-04-2022 To 28-04-2022
-: Stock News :- BIOCON 29-04-2022 To 28-04-2022

✔️ Biocon Biologics expects R&D expenses to hover between 10-15% in the next financial year
✔️ Encouraged by strong performance', says Kiran Mazumdar-Shaw on Biocon Q4 results
✔️ Biocon's March Quarter Profit Falls 4% To Rs 283 Crore
✔️ Biocon Q4 consolidated net profit declines by 4% to Rs 283 crore

View Full Story
-: Stock News :- BIOCON 26-04-2022 To 26-04-2022
-: Stock News :- BIOCON 26-04-2022 To 26-04-2022

✔️ Biocon Biologics bags $90 million contract from Malaysia govt
✔️ Biocon arm signs $90 million contract with Malaysia for human insulin brand Insugen
✔️ Biocon's arm gets $90 mn contract from Malaysian government for insulins
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins

View Full Story
-: Stock News :- BIOCON 29-03-2022 To 26-04-2022
-: Stock News :- BIOCON 29-03-2022 To 26-04-2022

✔️ Glasgow Uni names research centre after John Shaw and Kiran Mazumdar-Shaw
✔️ Biocon arm signs $90 million contract with Malaysia for human insulin brand Insugen
✔️ Biocon's arm gets $90 mn contract from Malaysian government for insulins
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins

View Full Story
-: Stock News :- BIOCON 23-03-2022 To 26-04-2022
-: Stock News :- BIOCON 23-03-2022 To 26-04-2022

✔️ Kiran Mazumdar-Shaw elected as fellow of Royal Society of Edinburgh
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins

View Full Story
-: Stock News :- BIOCON 04-03-2022 To 26-04-2022
-: Stock News :- BIOCON 04-03-2022 To 26-04-2022

✔️ Hold Biocon; target of Rs 390: ICICI Direct
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins

View Full Story
-: Stock News :- BIOCON 02-03-2022 To 26-04-2022
-: Stock News :- BIOCON 02-03-2022 To 26-04-2022

✔️ Biocon chief says India can help Biden fulfill his affordable insulin promise
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins

View Full Story
-: Stock News :- BIOCON 01-03-2022 To 27-02-2022
-: Stock News :- BIOCON 01-03-2022 To 27-02-2022

✔️ Post Viatris deal, eyes on execution for Biocon
✔️ Buy Biocon: target of Rs 420: Sharekhan
✔️ Neutral Biocon; target of Rs 385 : Motilal Oswal
✔️ Biocon's unit buys biosimilar assets of Viatris for $3.34 billion
✔️ Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 12-02-2022 To 27-02-2022
-: Stock News :- BIOCON 12-02-2022 To 27-02-2022

✔️ Rahul Bajaj Passes Away: Corporates, Political Leaders Express Grief
✔️ Buy Biocon: target of Rs 420: Sharekhan
✔️ Neutral Biocon; target of Rs 385 : Motilal Oswal
✔️ Biocon's unit buys biosimilar assets of Viatris for $3.34 billion
✔️ Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 08-02-2022 To 27-02-2022
-: Stock News :- BIOCON 08-02-2022 To 27-02-2022

✔️ Biocon gains 3%, at 6-month high in a weak market; stock up 18% in 3 weeks
✔️ Buy Biocon: target of Rs 420: Sharekhan
✔️ Neutral Biocon; target of Rs 385 : Motilal Oswal
✔️ Biocon's unit buys biosimilar assets of Viatris for $3.34 billion
✔️ Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 27-01-2022 To 27-02-2022
-: Stock News :- BIOCON 27-01-2022 To 27-02-2022

✔️ Accumulate BIOCON; target of Rs 422: Hem Securities
✔️ Buy Biocon: target of Rs 420: Sharekhan
✔️ Neutral Biocon; target of Rs 385 : Motilal Oswal
✔️ Biocon's unit buys biosimilar assets of Viatris for $3.34 billion
✔️ Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 24-01-2022 To 27-02-2022
-: Stock News :- BIOCON 24-01-2022 To 27-02-2022

✔️ Insulins access program for young expanded in Dec quarter: Biocon Biologics MD
✔️ Biocon Consolidated December 2021 Net Sales at Rs 2,174.20 crore, up 17.46% Y-o-Y
✔️ Neutral Biocon; target of Rs 385 : Motilal Oswal
✔️ Biocon's unit buys biosimilar assets of Viatris for $3.34 billion
✔️ Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 21-01-2022 To 27-02-2022
-: Stock News :- BIOCON 21-01-2022 To 27-02-2022

✔️ R&D expenditure will rise in the coming quarters: Biocon Biologics MD
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 19-01-2022 To 27-02-2022
-: Stock News :- BIOCON 19-01-2022 To 27-02-2022

✔️ Biocon share price surges after Morgan Stanley upgrades stock to 'outperform'
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 18-01-2022 To 27-02-2022
-: Stock News :- BIOCON 18-01-2022 To 27-02-2022

✔️ COVID-19: Would like to give booster doses to all employees', says Kiran Mazumdar-Shaw
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 07-01-2022 To 27-02-2022
-: Stock News :- BIOCON 07-01-2022 To 27-02-2022

✔️ USFDA rejects Biocon, Viatris application for Insulin Aspart
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 04-01-2022 To 27-02-2022
-: Stock News :- BIOCON 04-01-2022 To 27-02-2022

✔️ Biocon announces merger of its arm with Serum Institute subsidiary
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 30-12-2021 To 27-02-2022
-: Stock News :- BIOCON 30-12-2021 To 27-02-2022

✔️ Biocon Biologics partner Viatris wins favourable order from US court
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 20-12-2021 To 27-02-2022
-: Stock News :- BIOCON 20-12-2021 To 27-02-2022

✔️ Can booster doses prevent new variants? Here's what Kiran Mazumdar-Shaw has to say
✔️ Biocon rises over 3% as biotech major sees strong Dec qtr numbers
✔️ Biocon Q3: Net profit jumps 18% to Rs 220 cr
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 07-12-2021 To 27-02-2022
-: Stock News :- BIOCON 07-12-2021 To 27-02-2022

✔️ Why Biocon's earnings to get a boost after two muted years
✔️ Biocon ties up with Saudi drug firm Tabuk to commercialise speciality medicines
✔️ Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 02-12-2021 To 27-02-2022
-: Stock News :- BIOCON 02-12-2021 To 27-02-2022

✔️ Biocon gets USFDA nod for generic product
✔️ Biocon gets USFDA nod for generic product
✔️ Biotechnology major Biocon gets USFDA approval for generic product
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 01-12-2021 To 27-02-2022
-: Stock News :- BIOCON 01-12-2021 To 27-02-2022

✔️ Even if you don't have COVID...: Biocon chief on 6-hr wait at airports amid Omicron threat
✔️ Biocon to be listed on DJSI in Emerging Markets category
✔️ Biocon enters Dow Jones Sustainability Index in Emerging Markets category
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 21-11-2021 To 27-02-2022
-: Stock News :- BIOCON 21-11-2021 To 27-02-2022

✔️ A turnaround for Biocon likely post Semglee launch
✔️ Biocon to be listed on DJSI in Emerging Markets category
✔️ Biocon enters Dow Jones Sustainability Index in Emerging Markets category
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 19-11-2021 To 27-02-2022
-: Stock News :- BIOCON 19-11-2021 To 27-02-2022

✔️ Biocon Biologics, Viatris confirm offering steep savings on long-acting insulin through Walgreens Prescription Savings Club
✔️ Biocon to be listed on DJSI in Emerging Markets category
✔️ Biocon enters Dow Jones Sustainability Index in Emerging Markets category
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 16-11-2021 To 27-02-2022
-: Stock News :- BIOCON 16-11-2021 To 27-02-2022

✔️ Biocon launches inter-changeable biosimilar insulin in US
✔️ Biocon Biologics, Viatris launch biosimilar insulin glargine in US
✔️ Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 15-11-2021 To 27-02-2022
-: Stock News :- BIOCON 15-11-2021 To 27-02-2022

✔️ Biocon starts campaign to treat diabetic children, train healthcare workers
✔️ Biocon Biologics, Viatris launch biosimilar insulin glargine in US
✔️ Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 09-11-2021 To 27-02-2022
-: Stock News :- BIOCON 09-11-2021 To 27-02-2022

✔️ Covid reinforced global dependence on Indian IT sector: Kris Gopalakrishnan
✔️ Biocon Biologics, Viatris launch biosimilar insulin glargine in US
✔️ Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 26-10-2021 To 27-02-2022
-: Stock News :- BIOCON 26-10-2021 To 27-02-2022

✔️ Serum alliance will help margins from H2 of FY23: Biocon Biologics dy CEO
✔️ Biocon Biologics, Viatris launch biosimilar insulin glargine in US
✔️ Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 25-10-2021 To 27-02-2022
-: Stock News :- BIOCON 25-10-2021 To 27-02-2022

✔️ Buy Biocon: target of Rs 470: Sharekhan
✔️ Biocon Biologics, Viatris launch biosimilar insulin glargine in US
✔️ Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
✔️ Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
✔️ Biocon consolidated net profit rises 18% to Rs 220 crore in Q3
✔️ Biocon Biologics buys Viatris' biosimilars assets for up to $3 bn
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 22-10-2021 To 27-02-2022
-: Stock News :- BIOCON 22-10-2021 To 27-02-2022

✔️ Biocon Q2 results: Net profit up 11% at Rs 188 cr; revenue jumps 10% to Rs 1,945 cr
✔️ Biocon share price falls 5% after Q2 profit dips to Rs 138 crore
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon net rises 11% in Q2 to Rs 188 cr, revenue up 10% at Rs 1,945 cr
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 21-10-2021 To 27-02-2022
-: Stock News :- BIOCON 21-10-2021 To 27-02-2022

✔️ Biocon's insulin biosimilar Glargine gets preference in top US formulary
✔️ Biocon share price falls 5% after Q2 profit dips to Rs 138 crore
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon net rises 11% in Q2 to Rs 188 cr, revenue up 10% at Rs 1,945 cr
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 05-10-2021 To 27-02-2022
-: Stock News :- BIOCON 05-10-2021 To 27-02-2022

✔️ Pandora Papers: 'Kunal Kashyap has no influence over Biocon-linked trust'
✔️ Biocon share price falls 5% after Q2 profit dips to Rs 138 crore
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon net rises 11% in Q2 to Rs 188 cr, revenue up 10% at Rs 1,945 cr
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 04-10-2021 To 27-02-2022
-: Stock News :- BIOCON 04-10-2021 To 27-02-2022

✔️ Kiran Mazumdar-Shaw says husband's offshore trust wrongly implicated
✔️ Decoded: Of 'Pandora Papers', insider trading and Biocon link
✔️ Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
✔️ Biocon share price gains on launch of cancers drug in the US market
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 27-09-2021 To 27-02-2022
-: Stock News :- BIOCON 27-09-2021 To 27-02-2022

✔️ Biocon gets 6 observations from USFDA for its Malaysian facility in pre-approval inspection
✔️ Decoded: Of 'Pandora Papers', insider trading and Biocon link
✔️ Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
✔️ Biocon share price gains on launch of cancers drug in the US market
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 25-09-2021 To 27-02-2022
-: Stock News :- BIOCON 25-09-2021 To 27-02-2022

✔️ USFDA issues six observations post inspection of Biocon's Malaysian arm manufacturing facility
✔️ USFDA issues six observations after inspection of Biocon's Malaysian arm manufacturing facility
✔️ Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
✔️ Biocon share price gains on launch of cancers drug in the US market
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 23-09-2021 To 27-02-2022
-: Stock News :- BIOCON 23-09-2021 To 27-02-2022

✔️ Industry says UK's non-recognition of Indian vaccine certificates unfair'
✔️ USFDA issues six observations after inspection of Biocon's Malaysian arm manufacturing facility
✔️ Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
✔️ Biocon share price gains on launch of cancers drug in the US market
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 20-09-2021 To 27-02-2022
-: Stock News :- BIOCON 20-09-2021 To 27-02-2022

✔️ Can Serum deal provide a booster dose to Biocon's target price?
✔️ Vaccine access, biosimilars growth to boost Biocon's earnings outlook
✔️ Biocon Chief Says Husband's Trust Wrongly Implicated In Pandora Papers Leak
✔️ Biocon share price gains on launch of cancers drug in the US market
✔️ Biocon consolidated net profit dips 18% to Rs 138 crore in Q2
✔️ Biocon quarterly revenue up by 10%
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 17-09-2021 To 27-02-2022
-: Stock News :- BIOCON 17-09-2021 To 27-02-2022

✔️ Biocon-Serum alliance to build a global biotech powerhouse, say Kiran Mazumdar-Shaw, Adar Poonawalla
✔️ Biocon Gains After Arm Enters Strategic Alliance With Serum Institute
✔️ The daily dose: September 17, 2021
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn
✔️ Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 08-09-2021 To 27-02-2022
-: Stock News :- BIOCON 08-09-2021 To 27-02-2022

✔️ Biocon inks patent litigation settlement pact with Celgene
✔️ Revlimid drug: Biocon enters patent litigation settlement with Celgene
✔️ The daily dose: September 17, 2021
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn
✔️ Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 07-09-2021 To 27-02-2022
-: Stock News :- BIOCON 07-09-2021 To 27-02-2022

✔️ India to take 9 more months for full vaccination; avoid congregations: Shaw
✔️ Revlimid drug: Biocon enters patent litigation settlement with Celgene
✔️ The daily dose: September 17, 2021
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn
✔️ Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 30-07-2021 To 27-02-2022
-: Stock News :- BIOCON 30-07-2021 To 27-02-2022

✔️ The daily dose: July 30, 2021
✔️ Revlimid drug: Biocon enters patent litigation settlement with Celgene
✔️ The daily dose: September 17, 2021
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn
✔️ Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 29-07-2021 To 27-02-2022
-: Stock News :- BIOCON 29-07-2021 To 27-02-2022

✔️ Biocon, Viatris get USFDA's nod for interchangeable biosimilar product
✔️ Vaccines alone will not protect and make the world safer: Biocon chief
✔️ USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug
✔️ Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar product
✔️ Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 bn
✔️ Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics
✔️ Biocon Biologics to float in next two years: Kiran Mazumdar-Shaw
✔️ Biocon arm plans to acquire Viatris' biosimilars assets; stock falls 8%
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 27-07-2021 To 27-02-2022
-: Stock News :- BIOCON 27-07-2021 To 27-02-2022

✔️ Hold Biocon: target of Rs 400: ICICI Direct
✔️ Buy Biocon: target of Rs 470: Sharekhan
✔️ Coronavirus LIVE: Biocon joins Adagio for licence to make antibody cocktail
✔️ Biocon partners Adagio for licence to make Covid-19 antibody cocktail
✔️ US-based Adagio Therapeutics gives Biocon Biologics licence to make antibody treatment for Covid-19
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 23-07-2021 To 27-02-2022
-: Stock News :- BIOCON 23-07-2021 To 27-02-2022

✔️ Biocon net profit falls 35% to Rs 108 crore in Apr-Jun
✔️ Biocon Q1 net profit declines 35% to Rs 108.4 cr; revenue at Rs 1807.8 cr
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 01-07-2021 To 27-02-2022
-: Stock News :- BIOCON 01-07-2021 To 27-02-2022

✔️ Sebi bars Biocon's official from securities mkt for 3 months, levies fine
✔️ Biocon Q1 net profit declines 35% to Rs 108.4 cr; revenue at Rs 1807.8 cr
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 15-06-2021 To 27-02-2022
-: Stock News :- BIOCON 15-06-2021 To 27-02-2022

✔️ Covid has created an 'ecosystem' of innovation in India, says Biocon chief Kiran Mazumdar-Shaw
✔️ Covid has created an ecosystem of innovation in India: Kiran Mazumdar-Shaw
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 25-05-2021 To 27-02-2022
-: Stock News :- BIOCON 25-05-2021 To 27-02-2022

✔️ Hold Biocon: target of Rs 400: ICICI Direct
✔️ Covid has created an ecosystem of innovation in India: Kiran Mazumdar-Shaw
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 19-05-2021 To 27-02-2022
-: Stock News :- BIOCON 19-05-2021 To 27-02-2022

✔️ Sebi fines Biocon, its designated person for violating market norms
✔️ Covid has created an ecosystem of innovation in India: Kiran Mazumdar-Shaw
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 15-05-2021 To 27-02-2022
-: Stock News :- BIOCON 15-05-2021 To 27-02-2022

✔️ Biocon chief Kiran Mazumdar-Shaw compares COVID vaccination situation in India to arranged marriage
✔️ Biocon chief compares Covid vaccination in India to arranged marriage
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 12-05-2021 To 27-02-2022
-: Stock News :- BIOCON 12-05-2021 To 27-02-2022

✔️ Biocon perplexed' about Itolizumab not being in Covid protocol
✔️ Biocon chief compares Covid vaccination in India to arranged marriage
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 11-05-2021 To 27-02-2022
-: Stock News :- BIOCON 11-05-2021 To 27-02-2022

✔️ Biocon chief expresses concern over Covid-19 vaccine shortage
✔️ Biocon chief Kiran Mazumdar-Shaw expresses concern over Covid vaccine shortage
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 06-05-2021 To 27-02-2022
-: Stock News :- BIOCON 06-05-2021 To 27-02-2022

✔️ Covid second wave has hit India 'like a tsunami' says Kiran Mazumdar Shaw
✔️ Biocon chief Kiran Mazumdar-Shaw expresses concern over Covid vaccine shortage
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 03-05-2021 To 27-02-2022
-: Stock News :- BIOCON 03-05-2021 To 27-02-2022

✔️ Remdesivir supply issues might ease by third week of May: Biocon's Kiran Mazumdar-Shaw
✔️ Biocon chief Kiran Mazumdar-Shaw expresses concern over Covid vaccine shortage
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 02-05-2021 To 27-02-2022
-: Stock News :- BIOCON 02-05-2021 To 27-02-2022

✔️ Amid weak showing by biosimilars and generics, downgrade pressure on Biocon
✔️ Biocon chief Kiran Mazumdar-Shaw expresses concern over Covid vaccine shortage
✔️ Biocon Consolidated June 2021 Net Sales at Rs 1,760.60 crore, up 5.34% Y-o-Y
✔️ Biocon Standalone June 2021 Net Sales at Rs 382.70 crore, down 26.5% Y-o-Y
✔️ Biocon profit drops 44% in Q1FY22 due to subdued generics business, exceptional item
✔️ Biocon Biologics gets licence from Adagio for antibody Covid treatment
✔️ Biocon Biologics, Adagio Therapeutics sign pact for potential antibody treatment against COVID-19
✔️ Biocon likely to seek full marketing authorisation for Covid-19 drug
✔️ Biocon Biologics to acquire Viatris' biosimilars assets for $3.35 bn
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 30-04-2021 To 27-02-2022
-: Stock News :- BIOCON 30-04-2021 To 27-02-2022

✔️ Biocon Declines Over 3% After Net Profit Rose 105% In March Quarter
✔️ Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 26-04-2021 To 27-02-2022
-: Stock News :- BIOCON 26-04-2021 To 27-02-2022

✔️ Biocon Biologics, Viatris get EC nod for biosimilar drug Bevacizumab
✔️ Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 21-04-2021 To 27-02-2022
-: Stock News :- BIOCON 21-04-2021 To 27-02-2022

✔️ Demand spikes for Biocon's repurposed drug
✔️ Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 17-04-2021 To 27-02-2022
-: Stock News :- BIOCON 17-04-2021 To 27-02-2022

✔️ How to earn 13,000-profit with bull-call spread on Biocon
✔️ Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 12-04-2021 To 27-02-2022
-: Stock News :- BIOCON 12-04-2021 To 27-02-2022

✔️ Biocon Pharma gets GMP compliance certificate from MHRA
✔️ Biocon's arm gets GMP compliance certificate from UK's health regulator MHRA for Bengaluru facility
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 29-03-2021 To 27-02-2022
-: Stock News :- BIOCON 29-03-2021 To 27-02-2022

✔️ Biocon forms tie-up with Libbs Farmaceutica
✔️ Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 02-03-2021 To 27-02-2022
-: Stock News :- BIOCON 02-03-2021 To 27-02-2022

✔️ Biocon Biologics appoints Susheel Umesh as Chief Commercial Officer for emerging markets
✔️ Shreehas Tambe promoted as Deputy CEO of Biocon Biologics
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 01-03-2021 To 27-02-2022
-: Stock News :- BIOCON 01-03-2021 To 27-02-2022

✔️ Biocon Biologics, Viatris get CHMP nod for Abevmy
✔️ Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to Avastin
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 28-02-2021 To 27-02-2022
-: Stock News :- BIOCON 28-02-2021 To 27-02-2022

✔️ Companies 'feel betrayed' due to capping of Covid-19 vaccine price: Kiran Mazumdar Shaw
✔️ Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to Avastin
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 16-02-2021 To 27-02-2022
-: Stock News :- BIOCON 16-02-2021 To 27-02-2022

✔️ Centenary Celebrations of insulin: Biocon Biologics to partner with International Diabetes Federation
✔️ Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to Avastin
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 12-02-2021 To 27-02-2022
-: Stock News :- BIOCON 12-02-2021 To 27-02-2022

✔️ Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
✔️ Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 04-02-2021 To 27-02-2022
-: Stock News :- BIOCON 04-02-2021 To 27-02-2022

✔️ Biocon Biologics inks pact to expand access to its cancer biosimilars
✔️ Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 02-02-2021 To 27-02-2022
-: Stock News :- BIOCON 02-02-2021 To 27-02-2022

✔️ Neutral Biocon; target of Rs 385: Motilal Oswal
✔️ Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 01-02-2021 To 27-02-2022
-: Stock News :- BIOCON 01-02-2021 To 27-02-2022

✔️ Buy Biocon; target of Rs 470: Sharekhan
✔️ Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 28-01-2021 To 27-02-2022
-: Stock News :- BIOCON 28-01-2021 To 27-02-2022

✔️ Hold Biocon; target of Rs 450: ICICI Direct
✔️ Biocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 25-01-2021 To 27-02-2022
-: Stock News :- BIOCON 25-01-2021 To 27-02-2022

✔️ Delay in award of tenders, higher entry barriers to new markets restricting growth: Kiran Mazumdar Shaw
✔️ Biocon share price falls 2% after CLSA retains sell on stock
✔️ Biocon's APIs, generic formulations biz posts 578 cr revenues
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 22-01-2021 To 27-02-2022
-: Stock News :- BIOCON 22-01-2021 To 27-02-2022

✔️ Biocon stock slides on poor Q3 results, exit of biologics arm's MD
✔️ Christiane Hamacher quits as CEO of Biocon Biologics
✔️ Biocon Q3 net profit falls 19% to Rs 186.6 crore
✔️ Biocon reports 95% growth in profit at Rs 257 cr in Q4FY21
✔️ Biocon Consolidated March 2021 Net Sales at Rs 1,838.70 crore, up 16.3% Y-o-Y
✔️ Biocon posts profit of 254 crore for Q4
✔️ Biocon Biologics posts 53% growth in reveunes at 664 crore for Q4FY21
✔️ Biocon drug itolizumab in demand
✔️ Biocon Biologics' new monoclonal antibodies facility bags ISPE's 2021 award
✔️ Biocon's arm to acquire Viatris' Biosimilars Assets for up to $3.33 billion
✔️ Biocon Biologics acquires Viatris' biosimilars business in $3.3 bn deal

View Full Story
-: Stock News :- BIOCON 22-01-2021 To 21-01-2021
-: Stock News :- BIOCON 22-01-2021 To 21-01-2021

✔️ Market reacts negatively to Biocon's weaker results, exit of biologics' MD
✔️ Biocon shares plunge 9% post Q3 results
✔️ Biocon Consolidated December 2020 Net Sales at Rs 1,851.00 crore, up 5.89% Y-o-Y
✔️ Biocon Standalone December 2020 Net Sales at Rs 456.10 crore, down 9.02% Y-o-Y
✔️ Biocon Shares Fall After Profit Declines In December Quarter
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 08-01-2021 To 21-01-2021
-: Stock News :- BIOCON 08-01-2021 To 21-01-2021

✔️ Biocon shares up 2% after ADQ pumps Rs 555 crore in subsidiary
✔️ Biocon gains 2% after arm gets Rs 555 crore capital injection from ADQ
✔️ ADQ to buy 1.8% stake in Biocon arm for 555 cr
✔️ Abu Dhabi's ADQ to invest $75 mn in Biocon Biologics for 1.8% stake
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 29-12-2020 To 21-01-2021
-: Stock News :- BIOCON 29-12-2020 To 21-01-2021

✔️ Buy Biocon: target of Rs 520: Sharekhan
✔️ Biocon share price rises 2% on launch of Tacrolimus capsules in US
✔️ Biocon launches Tacrolimus capsules in US
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 28-12-2020 To 21-01-2021
-: Stock News :- BIOCON 28-12-2020 To 21-01-2021

✔️ Biocon: Street to keep an eye on CY21 launches, market share gains
✔️ Biocon share price rises 2% on launch of Tacrolimus capsules in US
✔️ Biocon launches Tacrolimus capsules in US
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 25-12-2020 To 21-01-2021
-: Stock News :- BIOCON 25-12-2020 To 21-01-2021

✔️ USFDA informs Biocon Biologics, Mylan of deferred action on Avastin biosimilar license application
✔️ USFDA informs Biocon, Mylan of deferred action on biosimilar license plea
✔️ Biocon launches Tacrolimus capsules in US
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 23-12-2020 To 21-01-2021
-: Stock News :- BIOCON 23-12-2020 To 21-01-2021

✔️ People who are infected should also take vaccine: Bharat Biotech Chairman
✔️ USFDA informs Biocon, Mylan of deferred action on biosimilar license plea
✔️ Biocon launches Tacrolimus capsules in US
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 15-12-2020 To 21-01-2021
-: Stock News :- BIOCON 15-12-2020 To 21-01-2021

✔️ Biocon Biologics inks pact with CSSC in Tanzania for its Mission 10 cents'
✔️ USFDA informs Biocon, Mylan of deferred action on biosimilar license plea
✔️ Biocon launches Tacrolimus capsules in US
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 14-12-2020 To 21-01-2021
-: Stock News :- BIOCON 14-12-2020 To 21-01-2021

✔️ Biocon Biologics gets CHMP market authorisation for rapid acting insulin
✔️ Biocon, Mylan's diabetic drug receives positive opinion from EMA panel
✔️ Biocon, Mylan's diabetic drug receives positive opinion from European Medicines Agency committee
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 04-12-2020 To 21-01-2021
-: Stock News :- BIOCON 04-12-2020 To 21-01-2021

✔️ Biocon may explore govt research initiatives for Itolizumab
✔️ Covid-19 vaccine: Biocon's US partner Equillium to withdraw Itolizumab trials
✔️ Biocon, Mylan's diabetic drug receives positive opinion from European Medicines Agency committee
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 03-12-2020 To 21-01-2021
-: Stock News :- BIOCON 03-12-2020 To 21-01-2021

✔️ Roshni Nadar tops Kotak Wealth and Hurun India's list of richest women
✔️ Covid-19 vaccine: Biocon's US partner Equillium to withdraw Itolizumab trials
✔️ Biocon, Mylan's diabetic drug receives positive opinion from European Medicines Agency committee
✔️ Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 24-11-2020 To 21-01-2021
-: Stock News :- BIOCON 24-11-2020 To 21-01-2021

✔️ Hopefully DCGI to give nod for Oxford's vaccine immediately: Biocon chief
✔️ Biocon To Buy 26% Stake In Hinduja Renewables Two
✔️ Biocon to acquire 26% stake in Hinduja Renewables Two
✔️ Biocon to buy 26% stake in Hinduja Renewables Two
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 19-11-2020 To 21-01-2021
-: Stock News :- BIOCON 19-11-2020 To 21-01-2021

✔️ Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term
✔️ Biocon To Buy 26% Stake In Hinduja Renewables Two
✔️ Biocon to acquire 26% stake in Hinduja Renewables Two
✔️ Biocon to buy 26% stake in Hinduja Renewables Two
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 07-11-2020 To 21-01-2021
-: Stock News :- BIOCON 07-11-2020 To 21-01-2021

✔️ Biocon Biologics to raise $150 million from Goldman Sachs at $3.94 billion valuation
✔️ Biocon Biologics gets Rs 1,125 cr capital infusion from Goldman Sachs
✔️ Biocon to acquire 26% stake in Hinduja Renewables Two
✔️ Biocon to buy 26% stake in Hinduja Renewables Two
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 05-11-2020 To 21-01-2021
-: Stock News :- BIOCON 05-11-2020 To 21-01-2021

✔️ Biocon plans 2,000-crore capex for generics biz
✔️ Biocon Biologics gets Rs 1,125 cr capital infusion from Goldman Sachs
✔️ Biocon to acquire 26% stake in Hinduja Renewables Two
✔️ Biocon to buy 26% stake in Hinduja Renewables Two
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 30-10-2020 To 21-01-2021
-: Stock News :- BIOCON 30-10-2020 To 21-01-2021

✔️ Biocon's partner Equillium gets USFDA nod to begin phase-3 trial of itolizumab on COVID-19 patients
✔️ Biocon ranked among top five biotech employers globally
✔️ Biocon to acquire 26% stake in Hinduja Renewables Two
✔️ Biocon to buy 26% stake in Hinduja Renewables Two
✔️ Sovereign wealth fund ADQ to invest $75 million in Biocon Biologics, deal values firm at around $4 billion
✔️ Biocon tanks 10% on lower-than-expected December quarter results
✔️ Biocon share price falls 9% after Q3 profit dips 18% YoY to Rs 186 crore
✔️ Arun Chandavarkar named Biocon Biologics MD
✔️ Biocon Biologics reports topline of 769 crore in Q3
✔️ Biocon net profit down 18 per cent to 169 cr on Covid impact
✔️ Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

View Full Story
-: Stock News :- BIOCON 23-06-2022 To 23-06-2022
-: Stock News :- BIOCON 23-06-2022 To 23-06-2022

✔️ Will bribery case impact Biocon's business? Expert weighs in

View Full Story
-: Stock News :- BIOCON 21-06-2022 To 20-06-2022
-: Stock News :- BIOCON 21-06-2022 To 20-06-2022

✔️ SEC recommendation in accordance with guidelines: Biocon Biologics
✔️ CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals
✔️ Biocon Biologics denies bribery charge; says it follows a strong code of conduct'
✔️ Biocon Biologics Denies Bribery Charge, Says Followed Regulations
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

View Full Story
-: Stock News :- BIOCON 20-06-2022 To 20-06-2022
-: Stock News :- BIOCON 20-06-2022 To 20-06-2022

✔️ Agnipath has job potential in corporate sector for youths: Industry leaders
✔️ CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals
✔️ Biocon Biologics denies bribery charge; says it follows a strong code of conduct'
✔️ Biocon Biologics Denies Bribery Charge, Says Followed Regulations
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

View Full Story
-: Stock News :- BIOCON 07-06-2022 To 20-06-2022
-: Stock News :- BIOCON 07-06-2022 To 20-06-2022

✔️ Biocon chief Kiran Majumdar-Shaw slams poor condition of Bengaluru roads
✔️ CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals
✔️ Biocon Biologics denies bribery charge; says it follows a strong code of conduct'
✔️ Biocon Biologics Denies Bribery Charge, Says Followed Regulations
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

View Full Story
-: Stock News :- BIOCON 19-05-2022 To 20-06-2022
-: Stock News :- BIOCON 19-05-2022 To 20-06-2022

✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
✔️ Biocon Biologics Denies Bribery Charge, Says Followed Regulations
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

View Full Story
-: Stock News :- BIOCON 03-05-2022 To 20-06-2022
-: Stock News :- BIOCON 03-05-2022 To 20-06-2022

✔️ Ireland regulator reports manufacturing deficiency at Biocon's plant
✔️ Ireland regulator reports manufacturing deficiency at Biocon's Bengaluru plant
✔️ CCI approves Serum Institute Life Sciences-Biocon Biologics deal
✔️ Biocon Biologics Denies Bribery Charge, Says Followed Regulations
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

View Full Story
-: Stock News :- BIOCON 30-04-2022 To 20-06-2022
-: Stock News :- BIOCON 30-04-2022 To 20-06-2022

✔️ Buy Biocon: target of Rs 420: Sharekhan
✔️ Neutral Biocon; target of Rs 410: Motilal Oswal
✔️ Hold Biocon; target of Rs 380: ICICI Direct
✔️ Biocon Biologics Denies Bribery Charge, Says Followed Regulations
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

View Full Story
-: Stock News :- BIOCON 29-04-2022 To 20-06-2022
-: Stock News :- BIOCON 29-04-2022 To 20-06-2022

✔️ Biocon Biologics expects R&D expenses to hover between 10-15% in the next financial year
✔️ Encouraged by strong performance', says Kiran Mazumdar-Shaw on Biocon Q4 results
✔️ Biocon's March Quarter Profit Falls 4% To Rs 283 Crore
✔️ Biocon Q4 consolidated net profit declines by 4% to Rs 283 crore
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

View Full Story
-: Stock News :- BIOCON 26-04-2022 To 20-06-2022
-: Stock News :- BIOCON 26-04-2022 To 20-06-2022

✔️ Biocon Biologics bags $90 million contract from Malaysia govt
✔️ Biocon arm signs $90 million contract with Malaysia for human insulin brand Insugen
✔️ Biocon's arm gets $90 mn contract from Malaysian government for insulins
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

View Full Story
-: Stock News :- BIOCON 29-03-2022 To 20-06-2022
-: Stock News :- BIOCON 29-03-2022 To 20-06-2022

✔️ Glasgow Uni names research centre after John Shaw and Kiran Mazumdar-Shaw
✔️ Biocon arm signs $90 million contract with Malaysia for human insulin brand Insugen
✔️ Biocon's arm gets $90 mn contract from Malaysian government for insulins
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

View Full Story
-: Stock News :- BIOCON 23-03-2022 To 20-06-2022
-: Stock News :- BIOCON 23-03-2022 To 20-06-2022

✔️ Kiran Mazumdar-Shaw elected as fellow of Royal Society of Edinburgh
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

View Full Story
-: Stock News :- BIOCON 04-03-2022 To 20-06-2022
-: Stock News :- BIOCON 04-03-2022 To 20-06-2022

✔️ Hold Biocon; target of Rs 390: ICICI Direct
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

View Full Story
-: Stock News :- BIOCON 02-03-2022 To 20-06-2022
-: Stock News :- BIOCON 02-03-2022 To 20-06-2022

✔️ Biocon chief says India can help Biden fulfill his affordable insulin promise
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Executive Chairperson Kiran Mazumdar-Shaw elected as RSE fellow
✔️ Biocon Biologics' arm gets $90 million contract from Malaysian government for supply of insulins
✔️ CBI arrests JDC for accepting bribe to waive off 3rd phase trial of Biocon's Insulin Aspart Injection
✔️ NSE seeks clarification from Biocon in relation to Joint Drugs Controller bribery case
✔️ CBI arrests jt drugs controller in bribery case to clear Biocon Biologics injection
✔️ Product approvals legitimate': Kiran Mazumdar-Shaw on bribe allegations against Biocon
✔️ Joint drugs controller nabbed taking bribe to clear Biocon Biologics' diabetes injection
✔️ Joint drugs controller nabbed taking bribe to clear Biocon unit's injection

View Full Story
-: Stock News :- BIOCON 06-07-2022 To 06-07-2022
-: Stock News :- BIOCON 06-07-2022 To 06-07-2022

✔️ Biocon arm Syngene ends contract with Bioinnovat Research over graft case

View Full Story
-: Stock News :- BIOCON 02-07-2022 To 02-07-2022
-: Stock News :- BIOCON 02-07-2022 To 02-07-2022

✔️ Centre suspends 3 scientists over fake Remdesivir sale in Covid 2nd wave

View Full Story
-: Stock News :- BIOCON 09-08-2022 To 09-08-2022
-: Stock News :- BIOCON 09-08-2022 To 09-08-2022

✔️ Biocon looks to shore up biosimilar business. Will its investment pay off?

View Full Story
-: Stock News :- BIOCON 04-08-2022 To 04-08-2022
-: Stock News :- BIOCON 04-08-2022 To 04-08-2022

✔️ SAT quashes insider trading charges against Biocon official Shreehas Tambe

View Full Story
-: Stock News :- BIOCON 29-07-2022 To 29-07-2022
-: Stock News :- BIOCON 29-07-2022 To 29-07-2022

✔️ We're geared to launch a new molecule every 1-2 years: Biocon Biologics MD

View Full Story
-: Stock News :- BIOCON 27-07-2022 To 27-07-2022
-: Stock News :- BIOCON 27-07-2022 To 27-07-2022

✔️ Biocon'sQ1 net profit up by 71 per cent to 144crore
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%

View Full Story
-: Stock News :- BIOCON 21-07-2022 To 27-07-2022
-: Stock News :- BIOCON 21-07-2022 To 27-07-2022

✔️ Biocon receives three US FDA observations on its Telangana plant
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%

View Full Story
-: Stock News :- BIOCON 06-07-2022 To 27-07-2022
-: Stock News :- BIOCON 06-07-2022 To 27-07-2022

✔️ Biocon arm Syngene ends contract with Bioinnovat Research over graft case
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%

View Full Story
-: Stock News :- BIOCON 02-07-2022 To 27-07-2022
-: Stock News :- BIOCON 02-07-2022 To 27-07-2022

✔️ Centre suspends 3 scientists over fake Remdesivir sale in Covid 2nd wave
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%

View Full Story
-: Stock News :- BIOCON 23-06-2022 To 27-07-2022
-: Stock News :- BIOCON 23-06-2022 To 27-07-2022

✔️ Will bribery case impact Biocon's business? Expert weighs in
✔️ Biocon net profit rises 71% to Rs 144 crore in June quarter
✔️ Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%

View Full Story

No More Records...